Form4insider filings, from the source

SEC Form 4 · accession 0000899243-18-030904

FATE THERAPEUTICS INC · FATE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Amir Nashat
Director
Period of report
Dec 11, 2018
Accepted (ET)
Dec 13, 2018 · 5:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434316

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Dec 11, 2018S79,634$16.7117D2,393,552ISee Footnote
Common StockF1,F3Dec 11, 2018S1,552$16.7117D2,392,000ISee Footnote
Common StockF1,F4Dec 11, 2018S546$16.7117D2,391,454ISee Footnote
Common StockF1,F5Dec 11, 2018S796$16.7117D2,390,658ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses